Sunday, 13 September 2026European Markets

Euro Surges 14% Against Dollar, Testing EU Export Competitiveness

The euro has appreciated 14% in 2025 as the US dollar hits its lowest level since 2022, creating new challenges for European exporters. The British pound gained 7% over the same period, though analysts at Mizuho Bank forecast potential weakness below $1.30. Safe-haven flows have pushed the Swiss franc higher amid shifting currency dynamics.

Euro Surges 14% Against Dollar, Testing EU Export Competitiveness
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.
Loading stream...

The euro has jumped 14% against the US dollar in 2025, reaching its strongest position since 2022 as the greenback experiences significant weakness across major currency pairs.

The currency appreciation poses immediate challenges for EU exporters who compete globally on price. German manufacturers and French industrial producers face margin pressure as euro-denominated goods become more expensive for buyers using dollars or dollar-pegged currencies.

The British pound gained 7% against the dollar in the same timeframe, though Jordan Rochester at Mizuho Bank warns sterling could fall below $1.30 despite recent strength. The pound traded at $1.3086 this week, down 0.5% from previous levels.

Simon Phillips, Managing Director at No1 Currency, notes ongoing pressure on the pound. Against the euro, sterling fell 0.4% to €1.13, its weakest level since April 2023.

The Swiss franc has strengthened on safe-haven flows as investors reposition amid forex volatility. Currency analysts point to geopolitical developments including Iran nuclear negotiations and Japanese yen movements as additional factors reshaping exchange rate dynamics.

The European Central Bank faces a policy dilemma. A stronger euro acts as monetary tightening by reducing import costs and dampening inflation, potentially allowing rate cuts. But euro strength simultaneously hurts export competitiveness for manufacturers in Germany, Italy, and France who depend on overseas sales.

European equity markets have rallied despite currency headwinds. The Stoxx 600 index reached a record 583.4 points, up 0.6%. France's CAC 40 gained 0.7% and Germany's DAX rose 0.9%.

Currency strategists expect continued dollar weakness to drive further euro appreciation in coming months. The shift reverses years of dollar strength that benefited European exporters. Companies with significant US revenue exposure face translation losses when converting dollar earnings back to euros.

The forex realignment represents a cyclical shift in global currency markets, with major implications for trade flows, corporate earnings, and central bank policy across the eurozone.

Source documents

Via News is a conduit. We point to the source documents behind this report — we don't replace them. Trace any claim to its source and decide what to trust. How we source

Source Trace Score3 source documents3 with a live linkVerifiability: Strong
  1. [1]News articleUk· November 12, 2025
    Pound hits two-year low against euro as Starmer under fire
  2. [2]News articleYahoo Finance· December 31, 2025
    Stock market today: Dow, S&P 500, Nasdaq post double-digit gains in 2025 as AI trade powers market once again
  3. [3]News articleYahoo Finance· February 17, 2026
    Stock market today: Dow, S&P 500, Nasdaq waver in volatile trading as AI anxiety lingers
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Capital Keeps Flowing as Enterprise Adoption and Government Contracts Validate the Bet
A late-August surge of nine-figure funding rounds (Socure, Stability AI, Generalist AI, Gatik, Regent Craft, Emerald AI, Owner) shows venture capital still pouring into AI infrastructure, identity/fintech, and autonomy, even as public-market sentiment stays jumpy — Palantir's stock fell 6% the same week it landed the Army's TITAN contract. UiPath's raised guidance and strong Q2 results, alongside efficiency breakthroughs like Multiverse Computing's model compression, point to real enterprise monetization catching up to the funding hype.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
JPMorgan Chase & Co.
Both facts record the same attribute (net_income) for JPMorgan Chase & Co. in the identical fiscal period (Q1 2026) and observation date (2026-03-31), but report values that differ by approximately 1 billion times: $16,494,000,000 vs $16.49. These cannot both be true simultaneously. The discrepancy suggests either a unit mismatch (e.g., one is total net income, the other earnings per share mislabeled as net_income), a decimal point error, or data entry corruption. For the same entity, attribute, and time period, only one value can be correct.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,280 source documents archived
Query this data → isubstrate.com